Manchester Grand Hyatt San Diego, San Diego, CA, USA

Dates to Remember 

July 1, 2026
Distribution of exhibitor prospectus and support opportunities to all prior supporting companies, and also available by request.

July 15, 2026
Nominations for 2027 Patient Advocate Leader Award, the Roscoe O. Brady Award, the Catalyst Award and the New Treatment Award (corporations achieving regulatory approval milestones) open.

August 1, 2026
Call for abstracts: Abstract submission website open. Registration for the conference and hotel block opens.

October 1, 2026 (17:00 CDT)
Deadline for abstract submission to WORLDSymposium 2027.

October 15, 2026
Deadline for submission of full-length manuscripts for peer-review in the “Lysosomes” issue of Molecular Genetics & Metabolism, February, 2027. Click here to access the Guide for Authors or to submit a paper. If you have any questions regarding the process for submitting a manuscript for the lysosomes issue, please contact the journal at mgm@elsevier.com.

November 1 to December 1, 2026
Late-breaking abstract submission open.
A limited number of late-breaking abstracts will be selected for platform presentation.

November 2, 2026
Notification of abstract acceptance for poster or platform presentation at WORLDSymposium 2027.

November 3, 2026
Notification of WORLDSymposium 2027 Young Investigator Awards.


IMPORTANT REMINDER for the 2027 ABSTRACT SUBMISSION PROCESS:

More details will be available once the abstract submission system is opened on August 1, 2026.

EACH individual listed as an author or co-author will be required to submit THEIR OWN disclosure prior to the submission of the scientific abstract.

Each listed author must complete THEIR OWN DISCLOSURE; NO ONE ELSE may submit the disclosure on behalf of another individual.

Abstracts cannot be submitted until all disclosures for all authors are completed.

Once an author completes their own disclosure, that same disclosure will be applied to ALL abstracts on which the individual is a listed author or co-author. 


WORLDSymposium 2027 Award Nominations Open July 15, 2026.


Preliminary Schedule at a Glance*

Download Schedule at a Glance (PDF)

Sunday Jan 31, 2027
Afternoon The Patient Voice
Monday Feb 1, 2027
Morning Roscoe O. Brady Award Basic Science
Afternoon Basic Science
Tuesday Feb 2, 2027
Morning Patient Advocate Leader Award & Young Investigator Award Translational Research
Afternoon Translational Research
Wednesday Feb 3, 2027
Morning New Treatment Award Clinical Applications
Afternoon Clinical Applications
Thursday Feb 4, 2027
Morning Keynote Address Contemporary Forum & Late-breaking Science
Afternoon Rapid Fire Abstract Challenge

*Subject to change.


Plan on attending the

23rd Annual WORLDSymposium

January 31, 2027: The Patient Voice

January 31 - February 4, 2027: Research Meeting

February 3, 2027: Robert J. Gorlin Symposium

Manchester Grand Hyatt San Diego, San Diego, CA, USA

Scientific Meeting Location & Accommodations

Manchester Grand Hyatt San Diego
1 Market Place,
San Diego, CA 92101
Phone: +1 (619) 232-1234
Website: hyatt.com

Hotel Room Block opens August 1, 2026. Learn more here.

Letters of Invitation

Your meeting registration confirmation will include a link to generate a customized letter of invitation, which can be used when applying for a visa.


About WORLDSymposium

WORLDSymposium™ is an annual research conference dedicated to lysosomal diseases.

WORLD is an acronym that stands for We’re Organizing Research on Lysosomal Diseases.

The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases.

This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.


Sign up for Updates